학술논문
Apalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): a randomised, placebo-controlled, double-blind, multinational, phase 3 study
Document Type
Article
Author
Saad, Fred ; Efstathiou, Eleni; Attard, Gerhardt; Flaig, Thomas W; Franke, Fabio; Goodman, Oscar B, Jr; Oudard, Stéphane; Steuber, Thomas; Suzuki, Hiroyoshi; Wu, Daphne; Yeruva, Kesav; De Porre, Peter; Brookman-May, Sabine; Li, Susan; Li, Jinhui; Thomas, Shibu; Bevans, Katherine B; Mundle, Suneel D; McCarthy, Sharon A; Rathkopf, Dana E
Source
In The Lancet Oncology November 2021 22(11):1541-1559
Subject
Language
ISSN
1470-2045